ABH Healthcare IPO Details
ABH Healthcare IPO Summary

ABH Healthcare IPO opens for subscription on 24 Aug 2026 and closes on 27 Aug 2026.The IPO will be listed on NSE with the tentative listing date set for 01 Sep 2026.
ABH Healthcare IPO price band has been fixed at ₹96 – ₹102 per share. The face value is ₹10 per share with a lot size of 1200.
ABH Healthcare IPO total issue size comprises 34,29,600 shares (aggregating up to ₹34.98 Cr). This includes a fresh issue of 34,29,600 shares (aggregating up to ₹34.98 Cr). Pre-issue shareholding stands at 80,00,000, which will increase to 1,14,29,600 post-issue.
ABH Healthcare IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.
ABH Healthcare IPO Lot Size :Individual Minimum is 2 lots (2,400 shares) amounting to ₹244,800. Individual Maximum is 2 lots (2,400 shares) amounting to ₹244,800. SHNI Minimum is 3 lots (3,600 shares) amounting to ₹367,200. SHNI Maximum is 8 lots (9,600 shares) amounting to ₹979,200. BHNI Minimum is 9 lots (10,800 shares) amounting to ₹1,101,600.
ABH Healthcare IPO Details
ABH Healthcare IPO Subscription
ABH Healthcare IPO Application Wise Breakup
ABH Healthcare IPO Dates
- 24 Aug 2026Opening dateOpen
- 27 Aug 2026Closing dateClose
- 28 Aug 2026Allotment Date Allotment
- 31 Aug 2026Initiation of RefundsRefund
- 31 Aug 2026Credit of SharesCredit
- 01 Sep 2026Listing dateListing
ABH Healthcare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2400 | ₹244,800 |
| Individual Maximum | 2 | 2400 | ₹244,800 |
| SHNI Minimum | 3 | 3600 | ₹367,200 |
| SHNI Maximum | 8 | 9600 | ₹979,200 |
| BHNI Minimum | 9 | 10800 | ₹1,101,600 |
ABH Healthcare IPO Reservation
Promoter Holding
Documents
ABH Healthcare IPO Valuations
ABH Healthcare Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 85.27 | 63.90 | 51.35 |
| Total Income | 52.59 | 49.32 | 41.39 |
| Profit After Tax | 5.64 | 5.35 | 1.66 |
| EBITDA | 14.72 | 13.20 | 6.89 |
| NET Worth | 17.27 | 11.60 | 6.30 |
| Reserves and Surplus | 9.34 | 9.69 | 4.35 |
| Total Borrowing | 45.75 | 33.78 | 30.59 |
| Amount in ₹ Crore | |||
About ABH Healthcare IPO
ABH Healthcare Ltd provides healthcare services, operates under the name "Anil Baghi Hospital". The company has 150 beds and offer 25 medical specialities, including cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.
The hospital has empaneled with 30 private and public health insurance providers and third-party administrators. The company also participates in major government healthcare schemes such as the Ex-Servicemen Contributory Health Scheme (ECHS), Railways, Food Corporation of India (FCI), Bharat Sanchar Nigam Limited (BSNL), and Ayushman Bharat - Sarbat Sehat Bima Yojana (ABSSBY).
As of June 30, 2026, it has a team of 37 doctors and 101 nurses.
Strength Of ABH Healthcare IPO
- Doctor led professional management team with proven execution capabilities.
- Delivering quality clinical care by attracting and retaining experienced and renowned clinicians.
- Diversified operations across clinical specialties, payor mix and hospitals.
- Robust operating infrastructure including information technology and modern equipments.
- Track record of stable operating and financial performance and growth.
Risk Of ABH Healthcare IPO
- The Company has been specifically formed for the purpose of acquisition of the business of M/s. Anil Baghi Hospital (sole proprietorship concern of one of our Promoters), thus we have limited operating history as a Company which may make it difficult for investors to evaluate our historical performance or future prospects.
- The Company has acquired M/s. Anil Baghi Hospital, the sole proprietorship concern of one of its Promoters after its incorporation vide Business Transfer Agreement dated March 16, 2022. Any future acquisition of other businesses could result in operating difficulties, integration issues and other adverse consequences due to the Company's limited past experience in businesses.
- The company is significantly dependent on the Company's key personnels, including its Promoters, Kamal Baghi, Saurabh Baghi, Vaishali Saini, senior management and other healthcare professionals and any loss of or the Company's inability to attract or retain such persons could adversely affect its business, financial condition, results of operations and cash flows.
- The Company's revenues are significantly dependent on its only hospital in Ferozepur, Punjab, any change in the economic or political circumstances in or around the areas of Ferozepur, could materially affect the Company's business, financial condition and results of operations.
- If the company is unable to keep pace with technological changes, new equipments and service introductions, changes in patients' needs and evolving industry standards as well as failures or malfunction of the Company's medical or other equipments, its business and financial condition may be adversely affected.
- The company rely on certain third parties, including suppliers, and also enter into contracts with third-party payers such as insurance companies, third party administrators, corporations and government departments. Termination, non-renewal or any breach of the conditions of such contracts could have a material adverse impact on the Company's business, financial condition and results of operations.
- The company operates in a highly regulated industry, and compliance with applicable safety, health, environmental and other governmental regulations and any violations of existing regulations may adversely affect the Company's business, results of operations and cash flows.
- The object of making unidentified acquisitions may lead to significant investments in the businesses that may not be sustainable in the long run, which may result in financial losses and negatively impact the company's overall portfolio.
- The company does not own the premises where the Company's Registered office and hospital are located. Any adverse event that requires it to vacate the said property may materially adversely affect its business operations and financial conditions.
- The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could materially and adversely affect the Company's reputation and prospects.
Objectives ABH Healthcare IPO
1. Repayment / prepayment, in part or full, of certain of our borrowings
2. Funding our Working Capital Requirements; and
3. Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as “Objects”)
Company Contact Details
ABH Healthcare Ltd.
Anil Baghi Road, Ferozepur,
Punjab
Firozpur, Punjab, 152002
Phone: +91 7888690018
Email: investor@anilbaghihospital.com
Website: https://www.abhhealthcare.org/
Registrar Contact Details
ABH Healthcare FAQs
The ABH Healthcare IPO is a SME public issue comprising 3429600 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹34.98 Cr. The issue price has been fixed at ₹102 per equity share, and the minimum application size is 1200 shares.
The IPO opens for subscription on 24 Aug 2026, and closes on 27 Aug 2026.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE
As of now, the current GMP stands at ₹0 (0%).

